BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34533937)

  • 1. Reversing Multidrug Resistance by Inducing Mitochondrial Dysfunction for Enhanced Chemo-Photodynamic Therapy in Tumor.
    Shi C; Huang H; Zhou X; Zhang Z; Ma H; Yao Q; Shao K; Sun W; Du J; Fan J; Liu B; Wang L; Peng X
    ACS Appl Mater Interfaces; 2021 Sep; 13(38):45259-45268. PubMed ID: 34533937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multifunctional nano-delivery system enhances the chemo-
    Zhao R; Ning X; Wang M; Yu A; Wang Y
    J Mater Chem B; 2021 Nov; 9(44):9174-9182. PubMed ID: 34698329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment.
    Assanhou AG; Li W; Zhang L; Xue L; Kong L; Sun H; Mo R; Zhang C
    Biomaterials; 2015 Dec; 73():284-95. PubMed ID: 26426537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor- and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis.
    Wang H; Zhang F; Wen H; Shi W; Huang Q; Huang Y; Xie J; Li P; Chen J; Qin L; Zhou Y
    J Nanobiotechnology; 2020 Jan; 18(1):8. PubMed ID: 31918714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOXC6 regulates the antitumor effects of pheophorbide a-based photodynamic therapy in multidrug-resistant oral cancer cells.
    Kim SA; Lee MR; Yoon JH; Ahn SG
    Int J Oncol; 2016 Dec; 49(6):2421-2430. PubMed ID: 27840908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance.
    Lei M; Ma G; Sha S; Wang X; Feng H; Zhu Y; Du X
    Drug Deliv; 2019 Dec; 26(1):262-272. PubMed ID: 30856352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating mitochondrial morphology enhances antitumor effect of 5-ALA-mediated photodynamic therapy both in vitro and in vivo.
    Zhao H; Yin R; Wang Y; Lee YH; Luo T; Zhang J; Qiu H; Ambrose S; Wang L; Ren J; Yao J; Chen D; Wang Y; Liang Z; Zhen J; Wu S; Ye Z; Zeng J; Huang N; Gu Y
    J Photochem Photobiol B; 2017 Nov; 176():81-91. PubMed ID: 28964889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation on vitamin e succinate based intelligent hyaluronic acid micelles for overcoming drug resistance and enhancing anticancer efficacy.
    Hou L; Tian C; Chen D; Yuan Y; Yan Y; Huang Q; Zhang H; Zhang Z
    Eur J Pharm Sci; 2019 Dec; 140():105071. PubMed ID: 31525433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-delivering-drug approach-based codelivery of paclitaxel and disulfiram for treating multidrug-resistant cancer.
    Mohammad IS; Teng C; Chaurasiya B; Yin L; Wu C; He W
    Int J Pharm; 2019 Feb; 557():304-313. PubMed ID: 30599232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-glycoprotein-targeted photodynamic therapy boosts cancer nanomedicine by priming tumor microenvironment.
    Mao C; Li F; Zhao Y; Debinski W; Ming X
    Theranostics; 2018; 8(22):6274-6290. PubMed ID: 30613297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-assisted engineering of programmed drug releasing multilayer nanomedicine via indomethacin-mediated ternary complex for therapy against a multidrug resistant tumor.
    Che L; Liu Z; Wang D; Xu C; Zhang C; Meng J; Zheng J; Yuan H; Zhao G; Zhou X
    Acta Biomater; 2019 Oct; 97():461-473. PubMed ID: 31344512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of long-acting TRAIL and tumor cell-targeted photodynamic therapy as a novel strategy to overcome chemotherapeutic multidrug resistance and TRAIL resistance of colorectal cancer.
    She T; Shi Q; Li Z; Feng Y; Yang H; Tao Z; Li H; Chen J; Wang S; Liang Y; Cheng J; Lu X
    Theranostics; 2021; 11(9):4281-4297. PubMed ID: 33754061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
    Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
    Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chamaejasmin B exerts anti-MDR effect in vitro and in vivo via initiating mitochondria-dependant intrinsic apoptosis pathway.
    Wang YJ; Li Q; Xiao HB; Li YJ; Yang Q; Kan XX; Chen Y; Liu XN; Weng XG; Chen X; Cai WY; Guo Y; Huang HF; Zhu XX
    Drug Des Devel Ther; 2015; 9():5301-13. PubMed ID: 26445529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response.
    Jiang L; Li L; He X; Yi Q; He B; Cao J; Pan W; Gu Z
    Biomaterials; 2015 Jun; 52():126-39. PubMed ID: 25818419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Singlet Oxygen-Responsive Polymeric Nanomedicine for Light-Controlled Drug Release and Image-Guided Photodynamic-Chemo Combination Therapy.
    Yang DC; Wang S; Weng XL; Zhang HX; Liu JY; Lin Z
    ACS Appl Mater Interfaces; 2021 Jul; 13(29):33905-33914. PubMed ID: 34278780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lenvatinib-zinc phthalocyanine conjugates as potential agents for enhancing synergistic therapy of multidrug-resistant cancer by glutathione depletion.
    Wei G; Huang L; Jiang Y; Shen Y; Huang Z; Huang Y; Sun X; Zhao C
    Eur J Med Chem; 2019 May; 169():53-64. PubMed ID: 30856406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways.
    Li N; Zhang CX; Wang XX; Zhang L; Ma X; Zhou J; Ju RJ; Li XY; Zhao WY; Lu WL
    Biomaterials; 2013 Apr; 34(13):3366-80. PubMed ID: 23410681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of mitochondrial targeting antiresistant epirubicin liposomes in treating resistant leukemia in animals.
    Men Y; Wang XX; Li RJ; Zhang Y; Tian W; Yao HJ; Ju RJ; Ying X; Zhou J; Li N; Zhang L; Yu Y; Lu WL
    Int J Nanomedicine; 2011; 6():3125-37. PubMed ID: 22163164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming drug-resistant lung cancer by paclitaxel-loaded hyaluronic acid-coated liposomes targeted to mitochondria.
    Tian Y; Zhang H; Qin Y; Li D; Liu Y; Wang H; Gan L
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2071-2082. PubMed ID: 30112929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.